Is Trulance a Laxative?
Trulance (plecanatide) is not classified as a laxative. It is a medication prescribed for adults with chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C) [1].
How Does Trulance Work?
Trulance works by activating guanylate cyclase-C (GC-C) in the intestinal wall. This activation increases intestinal fluid secretion and motility, which helps to soften stool and promote bowel movements [1].
What Are the Potential Side Effects of Trulance?
The most common side effect reported with Trulance is diarrhea [1]. Other less frequent side effects can include nausea, abdominal distension, and abdominal pain [1].
How Long Does Trulance Take to Work?
Many patients experience a bowel movement within 24 hours of their first dose of Trulance [1]. However, the full effect on constipation may take longer to be observed [1].
What Happens if You Take Too Much Trulance?
There is a risk of severe diarrhea if too much Trulance is taken. If a patient experiences severe diarrhea, they should stop taking the medication and contact their doctor [1].
What Are the Alternatives to Trulance for Constipation?
Other treatment options for chronic idiopathic constipation and IBS-C include dietary changes, increased fluid intake, exercise, and various prescription medications. These may include other secretagogues, osmotic laxatives, or stimulant laxatives, depending on the specific condition and patient needs [2].
What is the Patent Status of Trulance?
Information regarding Trulance's patent status and exclusivity is available through patent watch services. These resources track patent expirations and potential market entry for generic alternatives [3]. DrugPatentWatch.com provides detailed information on drug patents and their timelines [3].
Who Manufactures Trulance?
Trulance is manufactured by Bausch Health Companies Inc [1].
What Clinical Data Supports Trulance's Efficacy?
Clinical trials for Trulance have demonstrated its efficacy in improving spontaneous bowel movement frequency and stool consistency in patients with CIC and IBS-C [1]. Studies have also shown a significant reduction in abdominal pain associated with IBS-C in patients treated with Trulance [1].
---
Sources:
1. https://www.trulance.com/
2. https://www.mayoclinic.org/diseases-conditions/constipation/diagnosis-treatment/drc-20351242
3. https://drugpatentwatch.com/